The paraclinical examinations, principally the MRI have an increasing significance in the diagnosis of multiple sclerosis. However, MRI markers also have a prominent role in monitoring of the disease-course and activity, and also in the planning of possible therapeutic changes. In accordance with previously published international guidelines, in this article we propose a protocol for the monitoring the treatment efficacy in multiple sclerosis. This could be the basis of a consensus based guideline to be implemented in Hungary.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.18071/isz.71.0081 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!